Shielding the Fetus From the Coronavirus
New studies suggest the virus can cross the placenta, but newborns have been mildly affected if at all.
Los Angeles County officials reported Monday an additional 22 coronavirus-linked deaths, including a pregnant woman who had tested positive for the virus and had underlying health issues and a person who was incarcerated in a jail facility.
The new study included 770 hospital patients who hadn't previously been diagnosed with coronavirus infection. Of those, 30 tested positive for COVID-19. Of those who tested positive, 22 had no symptoms -- meaning the rate of positive tests among asymptomatic women was 2.9%.
Every time she has to buy groceries lately, Lily Marquez gets worried. She lives in a two-bedroom apartment in San Francisco with her two young children, her husband, her chronically ill mother-in-law, and her husband’s grandmother. Both of the older women are at high-risk of becoming severely ill if they get COVID-19, and she doesn’t want to be the one to infect them. But while many Americans have switched to online grocery shopping to avoid crowded spaces during the ongoing coronavirus pandemic, that’s not an option for Marquez—or the millions of other low-income women and children who rely on th...
Britain has begun cautiously easing lockdown restrictions despite warnings from some health officials that the risk of spreading COVID-19 is still too great. And in South Korea, the top infectious disease expert has pleaded with people over 65, pregnant women and other medically vulnerable individuals to stay at home as officials struggle to trace and stem the spread of the coronavirus amid increased public activity.
I am writing this as I lay in bed, feverish, sweaty, and persistent dry cough. I have been sick with presumed COVID-19 for the past ten days. I have quarantined myself from my wife and two sons, unable to hug or reassure them that everything will be okay. Additionally, my wife is 39 weeks pregnant. […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
The novel coronavirus (SARS-CoV-2) that arose in China in December 2019 resulted in an epidemic that quickly expanded with particular intensity in the United States and European countries, particularly Italy and Spain, devastating the foundations of our nations in one of the most significant public health threats of our time. Sadly, this disease has spread globally, and from March 12 on, the American Society for Reproductive Medicine and European Society of Human Reproduction and Embryology made similarly cautious recommendations on managing patients who were undergoing infertility therapy or desiring pregnancy, but withou...
Conclusion: There are several anesthetic considerations in the care of pregnant women with COVID-19 due to their unique physiological changes. We provide considerations and recommendations for departmental and institutional leadership as well as the obstetric anesthesia providers. These recommendations may apply and can be edited, for future droplet or airborne based pandemics. The rapidly evolving literature makes it important to get updates directly from the relevant medical societies' websites.
AbstractWe read with interest, the article by Gidl öf et al on the management of a twin pregnancy with severe preeclampsia and Coronavirus disease‐2019 (Covid‐19) and their call for more liberal testing guidelines in women with high‐risk pregnancies, and agree with their suggestion. A severe complication of preeclampsia is eclampsia. Presenta tions include neurological manifestations such as headache, seizures, loss of consciousness, along with raised blood pressure.
The global pandemic of SARS-CoV-2, the cause of Coronavirus disease 2019 (COVID-19), has been associated with worse outcomes in several patient populations, including the elderly and those with chronic comorbidities. Data from previous pandemics and seasonal influenza suggest that pregnant women may be at increased risk for infection-associated morbidity and mortality. Physiological changes in normal pregnancy and metabolic and vascular changes of high-risk pregnancies may affect pathogenesis or exacerbate the clinical presentation of COVID-19.
Since its emergence in December 2019, the outbreak of novel coronavirus disease 2019 (COVID-19) has infected over 2 626 321 people globally.1 COVID-19 is associated with wide variability in disease severity, ranging from asymptomatic to severe critical presentations. In initial data from China, mild thrombocytopenia was found to occur in just over a third of non-pregnant patients admitted to hospital with COVID-19. A more recent meta-analysis found that thrombocytopenia is associated with a three-fold greater risk of severe COVID-19.